Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.115984
Revised: December 3, 2025
Accepted: January 12, 2026
Published online: May 7, 2026
Processing time: 176 Days and 0.2 Hours
After four decades of intensive research, Helicobacter pylori (H. pylori), the gastric pathogen that fundamentally reshaped the understanding of peptic ulcer disease, remains notable resistance to standardized laboratory cultivation. This persistent technical challenge has significantly compromised reproducibility in both basic and clinical investigations. In a recent comparative study published in the World Journal of Gastroenterology, assessing ten liquid media across nine H. pylori strains, Kim et al demonstrated that growth efficiency and kinetic profiles are profoundly influenced by both medium composition and strain-specific characteristics. This commentary discusses the implications of these findings for microbial physiology, metabolic plasticity, and experimental reproducibility, arguing that the era of "precision microbiology" demands a more systematic and composition-driven approach to microbial cultivation. Reestablishing culture as a quantitative disci
Core Tip: Cultivating Helicobacter pylori (H. pylori) remains one of persistent challenges in microbiology due to its stringent nutritional and microaerophilic growth requirements. A recent comparative study across ten liquid media and nine H. pylori strains demonstrated that growth efficiency is highly dependent on both medium composition and strain-specific characteristics. Chopped meat carbohydrate broth, Columbia broth, and fastidious anaerobe broth supported significantly better growth than conventional Brucella broth. These findings underscore that culture media are not passive substrates but active determinants of microbial physiology. An ideal precision medium should be defined not only by its ability to support high biomass but also by its capacity to maintain H. pylori in its viable, spiral form. Such optimization may improve experimental reproducibility and facilitate advances in diagnostics, antimicrobial susceptibility testing, and vaccine development.
